Editas Medicine (EDIT)

Editas Medicine (EDIT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• EDIT last traded at $2.56, -3.93% on the day.
• Editas Medicine: market cap $410.06M, P/E -3.4, revenue $47.01M over the last four quarters, next earnings 2026-11-09.
• Over the past year EDIT returned -14.78%; year to date 25.12%.

Updated 2026-11-02 19:07 UTC